The potential pitfalls of PrEP

Lancet HIV. 2018 Nov 29:S2352-3018(18)30318-7. doi: 10.1016/S2352-3018(18)30318-7. Online ahead of print.

Authors

Mackenzie L Cottrell¹, Julie B Dumond²

Affiliations

¹ Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7361, USA.
² Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7361, USA. Electronic address: jdumond@unc.edu.

PMID: 30503323
DOI: 10.1016/S2352-3018(18)30318-7

No abstract available

Grants and funding

P30 AI050410/AI/NIAID NIH HHS/United States